Structure Therapeutics (GPCR) Net Equity Issued and Repurchased (2025)
Structure Therapeutics (GPCR) posted quarterly Net Equity Issued and Repurchased of $57.1 million for Q3 2025.
Structure Therapeutics (GPCR) Net Equity Issued and Repurchased (2025) Analysis & Trends
Structure Therapeutics' Net Equity Issued and Repurchased history runs 1 years deep, the most recent figure standing at $57.1 million for Q3 2025.
- In Q3 2025, Net Equity Issued and Repurchased changed N/A year-over-year to $57.1 million; the TTM figure through Sep 2025 stood at $57.1 million (changed N/A YoY), while the FY2025 annual figure was $57.1 million, down 88.91% from the prior year.
- Net Equity Issued and Repurchased for Q3 2025 stood at $57.1 million.
- The five-year high for Net Equity Issued and Repurchased was $57.1 million in Q3 2025, with the low at $57.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 49.20 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 141.90 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Structure Therapeutics | 11.65 Bn | 11.65 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 57.10 Mn |
| Sep 30, 2025 | 57.10 Mn |